By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Nivolumab And Relatlimab
Drugs

Nivolumab And Relatlimab

https://themeditary.com/drug/nivolumab-and-relatlimab-19289.html
Medically Reviewed by Glamora Samuels, MD TheMediTary.Com | Reviewed: Sep 27, 2023  Additional Content by TheMediTary.Com

Pregnancy & Lactation: Risk data not available

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Nivolumab And Relatlimab?

Nivolumab and relatlimab is used to treat people 12 years or older who weigh at least 88 lbs (40 kg) with a type of skin cancer called melanoma that has spread or cannot be removed by surgery.

Nivolumab and relatlimab may also be used for purposes not listed in this medication guide.

Warnings

Tell your doctor if you have ever had:

  • a nervous system problem, such as myasthenia gravis or Guillain-Barré syndrome;
  • a immune system problem, such as Crohn's disease, ulcerative colitis, or lupus;
  • received or plan to receive a stem cell transplant that uses donor stem cells; or
  • received an organ transplant.

May harm an unborn baby. You may need a pregnancy test to make sure you are not pregnant. Use effective birth control while using nivolumab and relatlimab and for at least 5 months after your last dose. Tell your doctor if you become pregnant.

Do not breastfeed while using this medicine, and for at least 5 months after your last dose.

How should I use Nivolumab And Relatlimab

Use Nivolumab And Relatlimab (Intravenous) exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.

Follow all directions on your prescription label and read all medication guides or instruction sheets.

Nivolumab and relatlimab is injected into a vein by a healthcare provider over 30 minutes.

Nivolumab and relatlimab is usually given every 4 weeks and your healthcare provider will tell you how many treatments you need.

Your treatment with nivolumab and relatlimab may be delayed or permanently discontinued if you have certain side effects.

You will need frequent blood tests to check for side effects.

What should I do if I missed a dose of Nivolumab And Relatlimab (Intravenous)?

Call your doctor for instructions if you miss an appointment for your nivolumab and relatlimab injection.

Nivolumab And Relatlimab side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection. Tell your medical caregiver if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, or swelling in your face.

Call your doctor at once if you have:

  • double or blurry vision;
  • severe muscle pain, cramps, or weakness;
  • confusion, sleep or memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness in your extremities;
  • lung problems--new or worsening cough, shortness of breath, or chest pain;
  • intestinal problems--diarrhea or more frequent bowel movements than usual, bloody or tarry stools, severe stomach pain or tenderness;
  • liver problems--swelling around your midsection, right-sided upper stomach pain, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
  • hormonal problems--headaches that will not go away or unusual headaches, sensitivity to light, eye problems, rapid heartbeat, increased sweating, extreme tiredness, weight gain or loss, feeling more hungry or thirsty than usual, urinating more often than usual, hair loss, feeling cold, constipation, deepened voice, dizziness, fainting, changes in mood or behavior;
  • kidney problems--swelling in your ankles, loss of appetite, urinating less, blood in your urine;
  • skin problems--rash, itching, skin blistering or peeling, sore or ulcers in mouth, nose, throat, or genital area;
  • heart problems--new or worse chest pain, irregular heartbeat, shortness of breath, tiredness, swelling in your ankles; or
  • low red blood cells (anemia)--pale skin, feeling light-headed or short of breath, cold hands and feet.

Common side effects may include:

  • muscle and bone pain;
  • rash, itching;
  • diarrhea;
  • tiredness; or
  • abnormal blood test results.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Nivolumab And Relatlimab?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

More about Nivolumab And Relatlimab

Drug images
Side effects
Drug class: Drugs
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by